FDA puts heavy restrictions on Avandia

Share this article:

The Food and Drug Administration announced Wednesday that effective Nov. 18, 2011, Avandia will be pulled from retail pharmacy shelves due to the diabetes drug's cardiovascular threat to patients.

A 2007 analysis conducted by the Cleveland Clinic cardiologist Steven Nissen, M.D., found that those with type 2 diabetes who took Avandia (rosiglitazone) had a 40% increase in heart attack risk. Several other studies confirmed the risk.

Starting Nov. 18, only certified doctors will be able to prescribe the drug, and only to patients who have been alerted to the risks, who have already taken the drug safely, and who have found that other medications did not control their diabetes. These patients can obtain Avandia through mail-order pharmacies.

Several cardiologists have criticized the FDA for failing to act sooner.

"It's like a decade-long nightmare coming to an end," Nissen told USA Today. "Eleven years after this drug was introduced, it will be so restricted in access that virtually no one will be able to get it."

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.